Overture Life, Inc. — Form D/A
Overture Life, Inc. of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2018-12-10. The offering totals $21.6M, of which $13.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-12-10
- Form: D/A
- Accession: 0001724645-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $21.6M
- Amount sold: $13.6M
- Remaining: $8.0M
- Investors: 10
- Date of first sale: 2017-12-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-301440
Issuer
- Name: Overture Life, Inc.
- CIK: 0001724645
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 117 EAST 57TH STREET, NEW YORK, NY, 10022
- Phone: (646) 270-4580
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Santiago Munn? | Director | New York, NY |
| Vijit Sabnis | Director | New York, NY |
| Mart?n Varsavsky | Director | New York, NY |
| Santiago Munn? | Executive Officer | New York, NY |
| Mart?n Varsavsky | Executive Officer | New York, NY |
Other filings by this issuer (1)
More